Eli Lilly and Company (@EliLillyandCo) “We’ve announced new data from the latest Phase 3 study of retatrutide, an invest” — TopicDigg
Eli Lilly and Company
@EliLillyandCo
Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad)
加入 July 2010
1.2K 正在关注 143.8K 粉丝
We’ve announced new data from the latest Phase 3 study of retatrutide, an investigational triple hormone receptor agonist.
